Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Cash Flow Conversion Efficiency

Latest as of September 2025: -0.002x

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret cash flow conversion efficiency. Based on the latest financial reports, Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) has a cash flow conversion efficiency ratio of -0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL-3.02 Million ≈ $-67.59K USD) by net assets (TL1.68 Billion ≈ $37.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (2018–2024)

Cash flow conversion efficiency of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret from 2018 to 2024. This chart illustrates how Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Anatolia Tani ve Biyoteknoloji Urunleri for real-time trading data and today's change.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Cash Flow Conversion Ratio Explained

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret ranked by their cash flow conversion efficiency. Also see ANGEN market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Tysnes Sparebank OL:TYSB	N/A
U Power Limited Ordinary Shares NASDAQ:UCAR	-0.118x
DarioHealth Corp NASDAQ:DRIO	-0.100x
Auric Mining Ltd AU:AWJ	0.143x
Avax One Technology Ltd. NASDAQ:AVX	-0.030x
Kronologi Asia Bhd KLSE:0176	-0.003x
P-Two Industries TWO:6158	-0.006x
S. Khonkaen Foods Public Company Limited BK:SORKON	0.071x

Annual Cash Flow Conversion Efficiency for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (2018–2024)

The table below shows the annual cash flow conversion efficiency of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret from 2018 to 2024. Review ANGEN free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	TL1.55 Billion ≈ $34.75 Million	TL141.41 Million ≈ $3.17 Million	0.091x	-62.37%
2023-12-31	TL1.75 Billion ≈ $39.23 Million	TL424.36 Million ≈ $9.50 Million	0.242x	-36.41%
2022-12-31	TL816.40 Million ≈ $18.29 Million	TL311.02 Million ≈ $6.97 Million	0.381x	-22.74%
2021-12-31	TL825.79 Million ≈ $18.50 Million	TL407.20 Million ≈ $9.12 Million	0.493x	-29.63%
2020-12-31	TL336.01 Million ≈ $7.53 Million	TL235.47 Million ≈ $5.27 Million	0.701x	+81.53%
2019-12-31	TL17.32 Million ≈ $387.97K	TL6.69 Million ≈ $149.77K	0.386x	+16.46%
2018-12-31	TL9.53 Million ≈ $213.55K	TL3.16 Million ≈ $70.79K	0.331x	--

About Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret

IS:ANGEN Turkey Medical Devices

Market Cap

$29.07 Million

TL1.30 Billion TRY

Market Cap Rank

#23693 Global

#350 in Turkey

Share Price

TL5.90

Change (1 day)

+7.86%

52-Week Range

TL5.33 - TL14.70

All Time High

TL23.13